Preeclampsia as modulator of offspring health

Biology of Reproduction

Volumn 94, Issue 3, 2016, Pages 1-10

  Stojanovska, Violeta ^a   Scherjonm, Sicco ^a   Plösch, Torsten ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Early development; Epigenetics; Metabolism; Preeclampsia

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTIBODY; ANTIBODY; UNCLASSIFIED DRUG; ANGIOGENIC FACTOR; ANGIOTENSIN 1 RECEPTOR; LEPTIN; RECEPTOR ANTIBODY;

CARDIOVASCULAR DISEASE; CHILD HEALTH; DISEASE COURSE; DISEASE PREDISPOSITION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; METABOLIC DISORDER; NON COMMUNICABLE DISEASE; NONHUMAN; PERMEABILITY; PHENOTYPE; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROGENY; SHORT SURVEY; ANIMAL; CHILD; FEMALE; FETUS DEVELOPMENT; PATHOLOGY; PREGNANCY; PRENATAL EXPOSURE; CARDIOVASCULAR SYSTEM; EPIGENETICS; EXPERIMENTAL STUDY; MEMBRANE PERMEABILITY; METABOLISM; MOLECULAR MECHANICS; SIGNAL TRANSDUCTION;

ANIMALS; CHILD; FEMALE; FETAL DEVELOPMENT; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 85007415358     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.115.135780     Document Type: Short Survey

References (143)

1. World Health Organization. WHO Noncommunicable Diseases Country Profiles. Geneva, Switzerland: WHO Press; 2014: 2014.
2. Pollex RL, Hegele RA. Genetic determinants of the metabolic syndrome. Nat Clin Pract Cardiovasc Med 2006; 3:482-489.
3. Mitchell BD, Imumorin IG. Genetic determinants of diabetes and atherosclerosis. Curr Atheroscler Rep 2002; 4:193-198.
4. Norman RE, Carpenter DO, Scott J, Brune MN, Sly PD. Environmental exposures: an underrecognized contribution to noncommunicable diseases. Rev Environ Health 2013; 28:59-65.
5. Jiménez-Chillarón JC, Díaz R, Martínez D, Pentinat T, Ramón-Krauel M, Ribó S, Plösch T. The role of nutrition on epigenetic modifications and their implications on health. Biochimie 2012; 94:2242-2263.
6. Carter AM. Evolution of placental function in mammals: the molecular basis of gas and nutrient transfer, hormone secretion, and immune responses. Physiol Rev 2012; 92:1543-1576.
7. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33:130-137.
8. Laresgoiti-Servitje E, Gomez-Lopez N. The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms. Biol Reprod 2012; 87: 36-36.
9. Redman CWG, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol 2010; 63:534-543.
10. Srinivas SK, Edlow AG, Neff PM, Sammel MD, Andrela CM, Elovitz MA. Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension? J Perinatol 2009; 29:680-684.
11. Weiler J, Tong S, Palmer KR. Is fetal growth restriction associated with a more severe maternal phenotype in the setting of early onset preeclampsia? A retrospective study. PLoS One 2011; 6:e26937.
12. Xiao R, Sorensen TK, Williams MA, Luthy DA. Influence of preeclampsia on fetal growth. J Matern Fetal Neonatal Med 2003; 13: 157-162.
13. Ødegard RA, Vatten LJ, Nilsen ST, Salvesen KA , Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol 2000; 96:950-955.
14. Eriksson JG, Forse T, Tuomilehto J, Osmond C. Early growth, adult income, and risk of stroke. Stroke 2000; 31:869-875.
15. Jong M, Lafeber HN, Cranendonk A, van Weissenbruch MM. Components of the metabolic syndrome in early childhood in verylow-birth-weight infants. Horm Res Paediatr 2014; 81:43-49.
16. Miller FC, Read JA, Cabal L, Siassi B. Heart rate and blood pressure in infants of pre-eclamptic mothers during the first hour of life. Crit Care Med 1983; 11:532-535.
17. Teng RJ, Wu TJ, Sharma R, Garrison RD, Hudak ML. Early neonatal hypotension in premature infants born to preeclamptic mothers. J Perinatol 2006; 26:471-475.
18. Davis EF, Newton L, Lewandowski AJ, Lazdam M, Kelly BA, Kyriakou T, Leeson P. Pre-eclampsia and offspring cardiovascular health: mechanistic insights from experimental studies. Clin Sci 2012; 123: 53-72.
19. Tenhola S, Rahiala E, Martikainen A, Halonen P, Voutilainen R. Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-yearold children born with maternal preeclampsia. J Clin Endocrinol Metab 2003; 88:1217-1222.
20. Miettola S, Hartikainen AL, Vaäräsmäki M, Bloigu A, Ruokonen A, Jarvelin MR, Pouta A. Offspring's blood pressure and metabolic phenotype after exposure to gestational hypertension in utero. Eur J Epidemiol 2013; 28:87-98.
21. Fraser A, Nelson SM, MacDonald-Wallis C, Sattar N, Lawlor DA. Hypertensive disorders of pregnancy and cardiometabolic health in adolescent offspring. Hypertension 2013; 62:614-620.
22. Tenhola S, Rahiala E, Halonen P, Vanninen E, Voutilainen R. Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring. Pediatr Res 2006; 59:320-324.
23. Lim W, Lee Y, Yap FK, Aris IM, Ngee L, Meaney M, Gluckman PD, Godfrey KM, Kwek K, Chong Y, Saw S. Maternal blood pressure during pregnancy and early childhood blood pressures in the offspring: the GUSTO birth cohort study. Med 2015; 94:1-9.
24. Fugelseth D, Ramstad HB, Kvehaugen AS, Nestaas E, Støylen A, Staff AC. Myocardial function in offspring 5-8years after pregnancy complicated by preeclampsia. Early Hum Dev 2011; 87:531-535.
25. Brodwall K, Leirgul E, Greve G, Vollset SE, Holmstrøm H, Tell GS, Øyen N. Possible common aetiology behind maternal preeclampsia and congenital heart defects in the child: a cardiovascular diseases in Norway project study. Paediatr Perinat Epidemiol 2015; 30:76-85.
26. Auger N, Fraser WD, Healy-Profitó s J, Arbour L. Association between preeclampsia and congenital heart defects. JAMA 2015; 314:1588.
27. Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJP. Preeclampsia is associated with increased risk of stroke in the adult offspring the Helsinki birth cohort study. Stroke 2009; 40:1176-1180.
28. Jayet PY, Rimoldi SF, Stuber T. Salinas Salmo`n C, Hutter D, Rexhaj E, Thalmann S, Schwab M, Turini P, Sartori-Cucchia C, Nicod P, Villena M, et al. Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation 2010; 122:488-494.
29. Hwang HS, Maeng YS, Park YW, Koos BJ, Kwon YG, Kim YH. Increased senescence and reduced functional ability of fetal endothelial progenitor cells in pregnancies complicated by preeclampsia without intrauterine growth restriction. Am J Obstet Gynecol 2008; 199:1-7.
30. Munãz-Hernandez R, Miranda ML, Stiefel P, Lin RZ, Praena-Fernández JM, Dominguez-Simeon MJ, Villar J, Moreno-Luna R, Melero-Martin JM. Decreased level of cord blood circulating endothelial colony-forming cells in preeclampsia. Hypertension 2014; 64:165-171.
31. Rodie VA, Caslake MJ, Stewart F, Sattar N, Ramsay JE, Greer IA, Freeman DJ. Fetal cord plasma lipoprotein status in uncomplicated human pregnancies and in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Atherosclerosis 2004; 176:181-187.
32. Wu CS, Nohr EA, Bech BH, Vestergaard M, Catov JM, Olsen J. Health of children born to mothers who had preeclampsia: a population-based cohort study. Am J Obstet Gynecol 2009; 201:269.
33. Washburn L, Nixon P, Russell G, Snively BM, O'Shea TM. Adiposity in adolescent offspring born prematurely to mothers with preeclampsia. J Pediatr 2013; 162:912-917.
34. Ophir E, Dourleshter G, Hirsh Y, Fait V, German L, Bornstein J. Newborns of pre-eclamptic women: a biochemical difference present in utero. Acta Obstet Gynecol Scand 2006; 85:1172-1178.
35. Guillemette L, Lacroix M, Allard C, Patenaude J, Battista M-C, Doyon M, Moreau J, Ménard J, Ardilouze J-L, Perron P, Coté A-M, Hivert M-F. Preeclampsia is associated with an increased pro-inflammatory profile in newborns. J Reprod Immunol 2015; 112:111-114.
36. Seppä S, Voutilainen R, Tenhola S. Markers of insulin sensitivity in 12-year-old children born from preeclamptic pregnancies. J Pediatr 2015; 167:125-130.
37. Powers RW, Jeyabalan A, Clifton RG, van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M. Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One 2010; 5:e13263.
38. Maynard SE, Min J, Merchan J, Lim K, Li J, Mondal S, Libermann TA, Morgon JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649-658.
39. Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Gonçalves LF, Gomez R, Edwin S. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia: Young Investigator Award. Am J Obstet Gynecol 2004; 190:1541-1550.
40. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355:992-1005.
41. Lu F, Bytautiene E, Tamayo E, Gamble P, Anderson GD, Hankins GDV, Longo M, Saade GR. Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am J Obstet Gynecol 2007; 197:1-5.
42. McDonnold M, Tamayo E, Kechichian T, Gamble P, Longo M, Hankins GDV, Saade GR, Costantine MM. The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model. Am J Obstet Gynecol 2014; 210:542.
43. Byers BD, Betancourt A, Lu F, Hankins GDV, Longo M, Saade GR, Bytautiene E. The effect of prepregnancy obesity and sFlt-1-induced preeclampsia-like syndrome on fetal programming of adult vascular function in a mouse model. Am J Obstet Gynecol 2009; 200:432.
44. Pruis MG, Gellhaus A, Kühnel E, Lendvai Á , Bloks VW, Groen AK, Plösch T. Sex-specific placental differences as a contributor to sexspecific metabolic programming? Acta Physiol 2015; 215:127-129.
45. Bytautiene E, Tamayo E, Kechichian T, Drever N, Gamble P, Hankins GDV, Saade GR. Prepregnancy obesity and sFlt1-induced preeclampsia in mice: developmental programming model of metabolic syndrome. Am J Obstet Gynecol 2011; 204:398.
46. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim K-H, Yuan H-T, Libermann TA, Stillman IE, Roberts D, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12:642-649.
47. Blázquez-Medela AM, García-Ortiz L, Gómez-Marcos MA, Recio-Rodríguez JI, Sánchez-Rodríguez A, López-Novoa JM, Martínez-Salgado C. Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients. BMC Med 2010; 8:86.
48. Siddiqui AH, Irani RA, Blackwell SC, Ramin SM, Kellems RE, Xia Y. Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension 2010; 55: 386-393.
49. Herse F, Lamarca B. Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension. Am J Reprod Immunol 2013; 69: 413-418.
50. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jüpner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999; 103:945-952.
51. Wenzel K, Rajakumar A, Haase H, Geusens N, Hubner N, Schulz H, Brewer J, Roberts L, Hubel CA, Herse F, Hering L, Qadri F, et al. Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension 2011; 58:77-84.
52. Hubel CA, Wallukat G, Wolf M, Herse F, Rajakumar A, Roberts JM, Markovic N, Thadhani R, Luft FC, Dechend R. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 2007; 49:612-617.
53. Irani RA, Zhang Y, Blackwell SC, Zhou CC, Ramin SM, Kellems RE, Xia Y. The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia. J Exp Med 2009; 206:2809-2822.
54. Zhang S, Zhang X, Yang L, Yan Z, Yan L, Tian J, Li X, Song L, Wang L, Yang X, Zheng R, Lau WB, et al. Increased susceptibility to metabolic syndrome in adult offspring of angiotensin type 1 receptor autoantibodypositive rats. Antioxid Redox Signal 2012; 17:733-743.
55. Chu KY, Tung L, Carlsson P-O, Leung PS, Angiotensin II. Type 1 receptor blockade improves b-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 2006; 55:367-374.
56. Lockwood CJ, Yen C-F, Basar M, Kayisli UA, Martel M, Buhimschi I, Buhimschi C, Huang SJ, Krikun G, Schatz F. Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am J Pathol 2008; 172:1571-1579.
57. Sharma A, Satyam A, Sharma JB. Leptin, IL-10 and inflammatory markers (TNF-alpha, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 2007; 58:21-30.
58. Lau SY, Guild SJ, Barrett CJ, Chen Q, Mccowan L, Jordan V, Chamley LW. Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. Am J Reprod Immunol 2013; 70:412-427.
59. Faas M, Schuiling G, Baller J, Visscher C, Bakker W. A new model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol 1994; 171:158-164.
60. Wei Y, Li X, Zhou J. Prenatal exposure to lipopolysaccharide results in increases in blood pressure and body weight in rats. Acta Pharmacol Sin 2007; 28:651-656.
61. Hao X-Q, Zhang H-G, Yuan Z-B, Yang D-L, Hao L-Y, Li X-H. Prenatal exposure to lipopolysaccharide alters the intrarenal renin-angiotensin system and renal damage in offspring rats. Hypertens Res 2010; 33: 76-82.
62. Wei Y, Du W, Xiong X, He X, Yi P, Deng Y, Chen D. Prenatal exposure to lipopolysaccharide results in myocardial remodelling in adult murine offspring. J Inflamm 2013; 10:35.
63. Zhao S, Zhang H, Cao D, Liu Y, Li X. Lipopolysaccharide exposure during pregnancy leads to aortic dysfunction in offspring rats. PLoS One 2014; 9:e102273.
64. Wang X, Luo H, Chen C, Chen K, Wang J, Cai Y, Zheng S, Yang X, Zhou L, Jose PA, Zeng C. Prenatal lipopolysaccharide exposure results in dysfunction of the renal dopamine D 1 receptor in offspring. Free Radic Biol Med 2014; 76:242-250.
65. Hao XQ, Du JX, Li Y, Li M, Zhang SY. Prenatal exposure to lipopolysaccharide combined with pre-and postnatal high-fat diet result in lowered blood pressure and insulin resistance in offspring rats. PLoS One 2014; 9:e88127.
66. Liu X, Wang B, Zhao M, Zhang C, Chen Y. Effects of maternal LPS exposure during pregnancy on metabolic phenotypes in female offspring. PLoS One 2014; 9:e114780.
67. Malassiné A, Frendo JL, Evain-Brion D. A comparison of placental development and endocrine functions between the human and mouse model. Hum Reprod Update 2003; 9:531-539.
68. Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol 2005; 1:98-114.
69. Lyall F, Robson SC, Bulmer JN. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction relationship to clinical outcome. Hypertension 2013; 62:1046-1054.
70. Sibley CP, Brownbill P, Dilworth M, Glazier JD. Review: adaptation in placental nutrient supply to meet fetal growth demand: Implications for programming. Placenta 2010; 31:S70-S74.
71. Gude NM, Roberts CT, Kalionis B, King RG. Growth and function of the normal human placenta. Thromb Res 2004; 114:397-407.
72. Powell TL, Jansson T, Illsley NP, Wennergren M, Korotkova M, Strandvik B. Composition and permeability of syncytiotrophoblast plasma membranes in pregnancies complicated by intrauterine growth restriction. Biochim Biophys Acta Biomembr 1999; 1420:86-94.
73. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002; 186:158-166.
74. Liévano S, Alarcón L, Chávez-Munguía B, González-Mariscal L. Endothelia of term human placentae display diminished expression of tight junction proteins during preeclampsia. Cell Tissue Res 2006; 324: 433-448.
75. Tossetta G, Paolinelli F, Avellini C, Salvolini E, Ciarmela P, Lorenzi T, Emanuelli M, Toti P, Giuliante R, Gesuita R, Crescimanno C, Voltolini C, et al. IL-1beta and TGF-beta weaken the placental barrier through destruction of tight junctions: an in vivo and in vitro study. Placenta 2014; 35:509-516.
76. Kajantie E, Thornburg KL, Eriksson JG, Osmond C, Barker DJP. In preeclampsia, the placenta grows slowly along its minor axis. Int J Dev Biol 2010; 54:469-473.
77. Rasmussen S, Irgens LM. Fetal growth and body proportion in preeclampsia. Obstet Gynecol 2003; 101:575-583.
78. Dahlgren J, Samuelsson AM, Jansson T, Holmäng A. Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation. Pediatr Res 2006; 60:147-151.
79. Miles PDG, Romeo OM, Higo K, Cohen A, Rafaat K, Olefsky JM. TNFalpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 1997; 46:1678-1683.
80. Cheung AT, Ree D, Kolls JK, Fuselier J, Coy DH, Bryer-Ash M. An in vivo model for elucidation of the mechanism of tumor necrosis factoralpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. Endocrinology 1998; 139: 4928-4935.
81. Kim HJ, Higashimori T, Park SY, Choi H, Dong JY, Kim YJ, Noh HL, Cho YR, Cline G, Kim YB, Kim JK. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 2004; 53:1060-1067.
82. Dechend R, Gieffers J, Dietz R, Joerres A, Rupp J, Luft FC, Maass M. Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation. Circulation 2003; 108:261-265.
83. Jin Z, Zhang W, Chai W, Zheng Y, Zhi J. Antibodies against AT1 receptors are associated with vascular endothelial and smooth muscle function impairment: protective effects of hydroxysafflor yellow A. PLoS One 2013; 8:e67020.
84. D'Hoker J, De Leu N, Heremans Y, Baeyens L, Minami K, Ying C, Lavens A, Chintinne M, Stangé G, Magenheim J, Swisa A, Martens G, et al. Conditional hypovascularization and hypoxia in islets do not overtly influence adult b-cell mass or function. Diabetes 2013; 62:4165-4173.
85. Herse F, Fain JN, Janke J, Engeli S, Kuhn C, Frey N, Weich HA, Bergmann A, Kappert K, Karumanchi SA, Luft FC, Muller DN, et al. Adipose tissue-derived soluble fms-like tyrosine kinase 1 is an obesityrelevant endogenous paracrine adipokine. Hypertension 2011; 58:37-42.
86. Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, Hacker MR, Rhee JS, Mitchell J, Mahmood F, Hess P, Farrell C, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012; 485: 333-338.
87. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114:1752-1761.
88. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440:944-948.
89. Tsukimori K, Fukushima K, Tsushima A, Nakano H. Generation of reactive oxygen species by neutrophils and endothelial cell injury in normal and preeclamptic pregnancies. Hypertension 2005; 46:696-700.
90. Matsubara K, Matsubara Y, Hyodo S, Katayama T, Ito M. Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. J Obstet Gynaecol Res 2010; 36:239-247.
91. Walsh SW, Vaughan JE, Wang Y, Roberts LJ. Placental isoprostane is significantly increased in preeclampsia. FASEB J 2000; 14:1289-1296.
92. Aris A, Benali S, Ouellet A, Moutquin J, Leblanc S. Potential biomarkers of preeclampsia: inverse correlation between hydrogen peroxide and nitric oxide early in maternal circulation and at term in placenta of women with preeclampsia. Placenta 2009; 30:342-347.
93. Dennery PA. Oxidative stress in development: nature or nurture? Free Radic Biol Med 2010; 49:1147-1151.
94. Mistry HD, Wilson V, Ramsay MM, Symonds ME, Pipkin FB. Reduced selenium concentrations and glutathione peroxidase activity in preeclamptic pregnancies. Hypertension 2008; 52:881-888.
95. Tsukahara H, Ohta N, Sato S, Hiraoka M, Shukunami K-I, Uchiyama M, Kawakami H, Sekine K, Mayumi M. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood. Free Radic Res 2004; 38:691-695.
96. Torrance HL, Krediet TG, Vreman HJ, Visser GH, van Bel F. Oxidative stress and proinflammatory cytokine levels are increased in premature neonates of preeclamptic mothers with HELLP syndrome. Neonatology 2008; 94:138-142.
97. Hilali N, Kocyigit A, Demir M, Camuzcuoglu A, Incebiyik A, Camuzcuoglu H, Vural M, Taskin A. DNA damage and oxidative stress in patients with mild preeclampsia and offspring. Eur J Obstet Gynecol Reprod Biol 2013; 170:377-380.
98. Erdem M, Harma M, Harma IM, Arikan I, Barut A. Comparative study of oxidative stress in maternal blood with that of cord blood and maternal milk. Arch Gynecol Obstet 2012; 285:371-375.
99. Braekke K, Harsem NK, Staff AC. Oxidative stress and antioxidant status in fetal circulation in preeclampsia. Pediatr Res 2006; 60:560-564.
100. Yaacobi N, Ohel G, Hochman A. Reactive oxygen species in the process of labor. Arch Gynecol Obs 1999; 263:23-24.
101. Lenzen S, Drinkgern J. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 1996; 20:463-466.
102. Kajiya M, Hirota M, Inai Y, Kiyooka T, Morimoto T, Iwasaki T, Endo K, Mohri S, Shimizu J, Yada T, Ogasawara Y, Naruse K, et al. Impaired NO-mediated vasodilation with increased superoxide but robust EDHF function in right ventricular arterial microvessels of pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol 2007; 292: H2737-H2744.
103. Richter HG, Camm EJ, Modi BN, Naeem F, Cross CM, Cindrova-Davies T, Spasic-Boskovic O, Dunster C, Mudway IS, Kelly FJ, Burton GJ, Poston L, et al. Ascorbate prevents placental oxidative stress and enhances birth weight in hypoxic pregnancy in rats. J Physiol 2012; 590: 1377-1387.
104. Roberts JM, Myatt L, Spong CY. Thom EA, Hauth JC, Leveno KJ, Pearson GD, Wapner RJ, Varner MW, Thorp JM, Mercer BM, Peaceman AM, et al. Vitamins C and E to prevent complications of pregnancyassociated hypertension. N Engl J Med 2010; 362:1282-1291.
105. Parrish RM, Martin NJ, Lamarca BB, Ellis B, Parrish AS, Owens YM, May LW. Randomized, placebo controlled, double blind trial evaluating early pregnancy phytonutrient supplementation in the prevention of preeclampsia. J Perinatol 2013; 33:593-599.
106. Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R, Godines M, Parry S, Macones G, Strauss JF. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ 2011; 342:d2901.
107. Yang R, Barouch LA. Leptin signaling and obesity: cardiovascular consequences. Circ Res 2007; 101:545-559.
108. Schrey S, Kingdom J, Baczyk D, Fitzgerald B, Keating S, Ryan G, Drewlo S. Leptin is differentially expressed and epigenetically regulated across monochorionic twin placenta with discordant fetal growth. Mol Hum Reprod 2013; 19:764-772.
109. Huynh FK, Neumann UH, Wang Y, Rodrigues B, Kieffer TJ, Covey SD. A role for hepatic leptin signaling in lipid metabolism via altered very low density lipoprotein composition and liver lipase activity in mice. Hepatology 2013; 57:543-554.
110. McCarthy JF, Misra DN, Roberts JM. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol 1999; 180:731-736.
111. Laivuori H, Kaaja R, Koistinen H, Karonen SL, Andersson S, Koivisto V, Ylikorkala O. Leptin during and after preeclamptic or normal pregnancy: its relation to serum insulin and insulin sensitivity. Metabolism 2000; 49:259-263.
112. Mise H, Yura S, Itoh H, Nuamah MA, Takemura M, Sagawa N, Fujii S. The relationship between maternal plasma leptin levels and fetal growth restriction. Endocr J 2007; 54:945-951.
113. Stepan H, Richter J, Kley K, Kralisch S, Jank A, Schaarschmidt W, Ebert T, Lössner U, Jessnitzer B, Kratzsch J, Blüher M, Stumvoll M, et al. Serum levels of growth arrest specific protein 6 are increased in preeclampsia. Regul Pept 2013; 182:7-11.
114. Eleuterio NM, Palei ACT, Rangel Machado JS, Tanus-Santos JE, Cavalli RC, Sandrim VC. Correlations between circulating levels of adipokines and anti-angiogenic factors in women with BMI ,30 and a late-onset preeclampsia. Hypertens Pregnancy 2014; 33:72-80.
115. Hauth JC, Clifton RG, Roberts JM, Myatt L, Spong CY, Leveno KJ, Varner MW, Wapner RJ, Thorp JM, Mercer BM, Peaceman AM, Ramin SM, et al. Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol 2011; 204:327.
116. Vrijkotte TGM, Krukziener N, Hutten BA, Vollebregt KC, Van Eijsden M, Twickler MB. Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study. J Clin Endocrinol Metab 2012; 97:3917-3925.
117. Zhang Z, Yang X, Zhang L, Duan Z, Jia L, Wang P, Shi Y, Li Y, Gao J. Decreased expression and activation of Stat3 in severe preeclampsia. J Mol Histol 2015; 46:205-219.
118. Ødegard RA, Vatten LJ, Nilsen ST, Salvesen KA , Austgulen R. Umbilical cord plasma leptin is increased in preeclampsia. Am J Obstet Gynecol 2002; 186:427-432.
119. Yuen BSJ, Owens PC, Symonds ME, Keisler DH, McFarlane JR, Kauter KG, McMillen IC. Effects of leptin on fetal plasma adrenocorticotropic hormone and cortisol concentrations and the timing of parturition in the sheep. Biol Reprod 2004; 70:1650-1657.
120. Kobayashi CI, Suda T. Regulation of reactive oxygen species in stem cells and cancer stem cells. J Cell Physiol 2012; 227:421-430.
121. Bauer S. Cytokine control of adult neural stem cells. Ann N Y Acad Sci 2009; 1153:48-56.
122. Chaudhari P, Ye Z, Jang Y-Y. Roles of reactive oxygen species in the fate of stem cells. Antioxid Redox Signal 2014; 20:1881-1890.
123. Poladia DP, Kish K, Kutay B, Bauer J, Baum M, Bates CM. Link between reduced nephron number and hypertension: studies in a mutant mouse model. Pediatr Res 2006; 59:489-493.
124. Corstius HB, Zimanyi MA, Maka N, Herath T, Thomas W, Van Der Laarse A, Wreford NG, Black MJ. Effect of intrauterine growth restriction on the number of cardiomyocytes in rat hearts. Pediatr Res 2005; 57:796-800.
125. Hinchliffe SA, Lynch MR, Sargent PH, Howard CV, Van Velzen D. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 1992; 99:296-301.
126. Cebrian C, Asai N, D'Agati V, Costantini F. The number of fetal nephron progenitor cells limits ureteric branching and adult nephron endowment. Cell Rep 2014; 7:127-137.
127. Stanger BZ, Tanaka AJ, Melton DA. Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver. Nature 2007; 445:886-891.
128. Terman A, Kurz T, Navratil M, Arriaga EA, Brunk UT. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondriallysosomal axis theory of aging. Antioxid Redox Signal 2010; 12: 503-535.
129. Rafalski VA, Mancini E, Brunet A. Energy metabolism and energysensing pathways in mammalian embryonic and adult stem cell fate. J Cell Sci 2012; 125:5597-5608.
130. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008; 132:567-582.
131. Ellis HL, Shioda K, Rosenthal NF, Coser KR, Shioda T. Masculine epigenetic sex marks of the CYP19A1/aromatase promoter in genetically male chicken embryonic gonads are resistant to estrogen-induced phenotypic sex conversion. Biol Reprod 2012; 87:23.
132. Marcho C, Bevilacqua A, Tremblay KD, Mager J. Tissue-specific regulation of Igf2r/Airn imprinting during gastrulation. Epigenetics Chromatin 2015; 8:10.
133. Cantone I, Fisher AG. Epigenetic programming and reprogramming during development. Nat Struct Mol Biol 2013; 20:282-9.
134. Orozco LD, Rubbi L, Martin LJ, Fang F, Hormozdiari F, Che N, Smith AD, Lusis AJ, Pellegrini M. Intergenerational genomic DNA methylation patterns in mouse hybrid strains. Genome Biol 2014; 15:R68.
135. Nissenbaum J, Bar-Nur O, Ben-David E, Benvenisty N. Global indiscriminate methylation in cell-specific gene promoters following reprogramming into human induced pluripotent stem cells. Stem Cell Reports 2013; 1:509-517.
136. Hu W, Weng X, Dong M, Liu Y, Li W, Huang H. Alteration in methylation level at 11b-hydroxysteroid dehydrogenase type 2 gene promoter in infants born to preeclamptic women. BMC Genet 2014; 15: 96.
137. He J, Zhang A, Fang M, Fang R, Ge J, Jiang Y, Zhang H, Han C, Ye X, Yu D, Huang H, Liu Y, et al. Methylation levels at IGF2 and GNAS DMRs in infants born to preeclamptic pregnancies. BMC Genomics 2013; 14:472.
138. Aufdenblatten M, Baumann M, Raio L, Dick B, Frey BM, Schneider H, Surbek D, Hocher B, Mohaupt MG. Prematurity is related to high placental cortisol in preeclampsia. Pediatr Res 2009; 65:198-202.
139. Bourque DK, Avila L, Penãherrera M, von Dadelszen P, Robinson WP. Decreased placental methylation at the H19/IGF2 imprinting control region is associated with normotensive intrauterine growth restriction but not preeclampsia. Placenta 2010; 31:197-202.
140. Ching T, Ha J, Song M-A, Tiirikainen M, Molnar J, Berry MJ, Towner D, Garmire LX. Genome-scale hypomethylation in the cord blood DNAs associated with early onset preeclampsia. Clin Epigenetics 2015; 7.
141. Reddington JP, Perricone SM, Nestor CE, Reichmann J, Youngson NA, Suzuki M, Reinhardt D, Dunican DS, Prendergast JG, Mjoseng H, Ramsahoye BH, Whitelaw E, et al. Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes. Genome Biol 2013; 14:R25.
142. Li Y, Zhang Y, Li S, Lu J, Chen J, Zhao Z, Bai J, Xu J, Li X. Genomewide DNA methylome analysis reveals novel epigenetically dysregulated non-coding RNAs in human breast cancer. Sci Rep 2014; 1-12.
143. Jin Z, Zhang W, Yang H, Wang X, Zheng Y, Zhang Q, Zhi J. Maternal treatment with agonistic autoantibodies against type-1 angiotensin ii receptor in late pregnancy increases apoptosis of myocardial cells and myocardial susceptibility to ischemia-reperfusion injury in offspring rats. PLoS One 2013; 8:e80709.